| Literature DB >> 34210199 |
Abstract
In this perspective, the authors paint a vision for industrializing drug discovery with an "atoms and bits" approach. This approach leverages advancements in machine learning, automation, and biological tools to create a platform for drug discovery that de-specializes the output of insights and generates feedback loops to iterate on each success and failure. Recursion Pharmaceuticals, where the authors work, is provided as an example of how one company is attempting to achieve this vision.Entities:
Keywords: automation; cell painting; drug discovery; high-throughput screening; machine learning
Mesh:
Year: 2021 PMID: 34210199 DOI: 10.1177/24725552211028124
Source DB: PubMed Journal: SLAS Discov ISSN: 2472-5552 Impact factor: 3.341